US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Biotech Top 5 Bull 2X ETF

45.76

-0.0856-0.19%

Volume:1K

Turnover:47.99K

Market Cap:5.72M

PE:- -

High:45.76

Open:45.67

Low:45.67

Close:45.85

52wk High:45.88

52wk Low:25.71

Shares:125.00K

Float Shares:125.00K

Volume Ratio:0.57

T/O Rate:0.84%

Dividend:0.62

Dividend Rate:1.36%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Is Pasatru’s Rare Disease Approval With Home Infusion Potential Altering The Investment Case For Regeneron Pharmaceuticals (REGN)?

Simply Wall St.

Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others

Circio boosts circVec gene therapy data and secures funding runway to 2030

Political and General News Events from August 31

Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients

MT Newswires Live

Amgen Repatha reduces risk of death in high-risk adults for first heart attack

Amgen's Repatha® Reduces Risk of Death in Patients at High Risk for a First Heart Attack or Stroke

THOMSON REUTERS

Protagonist announces Takeda received U.S. FDA approval for MIMRYLO

Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run

Simply Wall St.

Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO

Takeda receives FDA approval of NDA for Mimrylo

Crinetics Shareholders Approve Vertex Acquisition at Special Meeting

Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo

Vertex Tests VX-407’s Impact on Birth Control: What It Means for VRTX Investors

Amgen’s Pediatric Psoriasis Study Wrap-Up: What Apremilast Safety Data Means for Investors

Political and General News Events from August 28

Gilead Breaks Ground on Foster City Biologics Facility in $32 Billion US Investment Push

Gilead Sciences Director Anthony Welters Disposes of USD 2.64 Million in Common Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/TBXU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TBXU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","market":"US","secType":"STK","nameCN":"Direxion Daily Biotech Top 5 Bull 2X ETF","latestPrice":45.76,"timestamp":1788465600000,"preClose":45.8456,"halted":0,"volume":1049,"delay":0,"changeRate":-0.0018671366499729408,"floatShares":125000,"shares":125000,"eps":0,"marketStatus":"Pre-Mkt","change":-0.0856,"latestTime":"09-04 07:49:56 EDT","open":45.67,"high":45.76,"low":45.67,"amount":47994.050457,"amplitude":0.001963,"askPrice":72.75,"askSize":100,"bidPrice":39.39,"bidSize":8,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788528600000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":45.76,"sharesOutstanding":100001,"nav":45.771,"aum":5721480.2,"dividendRate":0.013588,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":45.76,"preClose":45.76,"latestTime":"18:10 EDT","volume":55,"amount":2564.41,"timestamp":1788473433517,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.57159603361788},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","floatShares":125000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.57159603361788,"shares":125000,"dividePrice":0.6218,"high":45.76,"amplitude":0.001963,"preClose":45.8456,"low":45.67,"week52Low":25.71,"pbRate":"--","week52High":45.88,"institutionHeld":0,"latestPrice":45.76,"committee":-0.851852,"eps":0,"divideRate":0.013588,"volume":1049,"delay":0,"ttmEps":0,"open":45.67,"prevYearClose":31.065,"prevWeekClose":42.5761,"prevMonthClose":42.9245,"prevQuarterClose":32.1223,"fiveDayClose":44.2151,"twentyDayClose":35.638,"sixtyDayClose":29.6083},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TBXU\",params:#limit:5,,,undefined,":[{"date":"2026-06-23","symbol":"TBXU","amount":0.11101,"announcedDate":"2026-06-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-23","defaultRemindTime":1782221400000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-23","currency":"USD","dateTimestamp":1782187200000,"payDate":"2026-06-30"},{"date":"2026-03-24","symbol":"TBXU","amount":0.09893,"announcedDate":"2026-03-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-24","defaultRemindTime":1774359000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-24","currency":"USD","dateTimestamp":1774324800000,"payDate":"2026-03-31"},{"date":"2025-12-23","symbol":"TBXU","amount":0.10111,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-31"},{"date":"2025-12-10","symbol":"TBXU","amount":0.31143,"announcedDate":"2025-12-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-10","defaultRemindTime":1765377000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-17","payableDate":"2025-12-10","currency":"USD","dateTimestamp":1765342800000,"payDate":"2025-12-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TBXU\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-10","recordDate":"2025-12-10","paymentDate":"2025-12-17","value":0.31143,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-31","value":0.10111,"currency":"USD"},{"executeDate":"2026-03-24","recordDate":"2026-03-24","paymentDate":"2026-03-31","value":0.09893,"currency":"USD"},{"executeDate":"2026-06-23","recordDate":"2026-06-23","paymentDate":"2026-06-30","value":0.11101,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TBXU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TBXU\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664854881","title":"Is Pasatru’s Rare Disease Approval With Home Infusion Potential Altering The Investment Case For Regeneron Pharmaceuticals (REGN)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664854881","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664854881?lang=en_us&edition=fundamental","pubTime":"2026-09-01 07:17","pubTimestamp":1788218267,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals has secured past FDA approval for Pasatru (garetosmab-grts), a VelocImmune-derived monoclonal antibody that reduces new heterotopic ossification lesions and clinician-assessed flare-ups in adults with fibrodysplasia ossificans progressiva, based on Phase 3 OPTIMA trial data.\nThis approval introduces a new rare disease therapy that can be infused monthly, including in home settings, and is supported by strong lesion-reduction outcomes against placebo while carrying...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/is-pasatrus-rare-disease-approval-with-home-infusion-potenti","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/is-pasatrus-rare-disease-approval-with-home-infusion-potenti","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VTHR","BK4588","TBXU","LU0053666078.USD","QTOC","AIPO","HBCP","LU2362541513.USD","LU0823434583.USD","BBH","LU0109394709.USD","BK4139","LU0823434740.USD","BK4585","LU2362540622.SGD","AGIX","REGN","BK4195","LU1917777945.USD","LU0289739699.SGD","LU0882574055.USD","LU2237438978.USD","LU0320765992.SGD","CHAT","IBBQ","LU2468319806.SGD","LU0823416689.USD","LU0058720904.USD","LU2106854487.HKD","LU2089984988.USD","LU0889565916.HKD","LU2023250504.SGD","LU0114720955.EUR","IBB","LU2362541273.HKD","LU1974910355.USD","ARTY","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664925888","title":"Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2664925888","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664925888?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:53","pubTimestamp":1788205998,"startTime":"0","endTime":"0","summary":"UPDATE 2-Trump administration announces drug pricing deals with CSL, Astellas and othersWASHINGTON, Aug 31 (Reuters)-U.S. President Donald Trump announced a new round of drug-pricing agreements with i","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S0RA:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0306806265.USD","CSL.AU","OZEM","BK4007","LU1883839398.USD","LU2112291526.USD","BIB","BK4550","PBE","IE00B3T34201.USD","BK0012","IBBQ","300485","IE00BJT1NW94.SGD","IBB","BK7511","SGXZ57979304.SGD","IE00BLSP4452.SGD","LU1057294990.SGD","SG9999001176.SGD","BK4566","SG9999002224.SGD","LU0225284248.USD","IE00BJJMRZ35.SGD","688235","PJP","LU1894683348.USD","AMGN","LU2242646821.SGD","IONS","LU0321505439.SGD","BK0046","LU0889565916.HKD","IE0002270589.USD","LU0109394709.USD","PFE","BK4534","BBH","IE00BLSP4239.USD","IE00BBT3K403.USD","LU0868494617.USD","TBXU","IE0002141913.USD","LU1983299246.USD","IE00BFTCPJ56.SGD","LU0320765992.SGD","BK0028","BBIO","LU2468319806.SGD","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664000711","title":"Circio boosts circVec gene therapy data and secures funding runway to 2030","url":"https://stock-news.laohu8.com/highlight/detail?id=2664000711","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664000711?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:03","pubTimestamp":1788203022,"startTime":"0","endTime":"0","summary":"The latest update is out from Targovax ASA ( ($GB:0RIS) ). Circio Holding ASA reported that new preclinical data show its circVec circular RNA tech...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/circio-boosts-circvec-gene-therapy-data-and-secures-funding-runway-to-2030?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/circio-boosts-circvec-gene-therapy-data-and-secures-funding-runway-to-2030?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBBQ","FBT","IBB","SYNB","TBXU","CNCR","GNOM","BK4139","BK4588","LFSC","BK4585","BK4505","IE0009354923.USD","RNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663005748","title":"Political and General News Events from August 31","url":"https://stock-news.laohu8.com/highlight/detail?id=2663005748","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663005748?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:15","pubTimestamp":1788182117,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from August 31Aug 31 (Reuters)-For other diaries, please see:Political andGeneral NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG/DI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4N44S10Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2112291526.USD","IE00BJT1NW94.SGD","PJP","BK4534","BK4588","LU1571399168.USD","LU2468319806.SGD","IE00BJJMRZ35.SGD","BK4585","BK4581","LU1983299246.USD","BBH","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU2242652126.USD","BIB","LU2242646821.SGD","TBXU","IBB","LU2089984988.USD","LU0058720904.USD","LU0320765992.SGD","LU0289739699.SGD","LU0122379950.USD","LU1023059063.AUD","LU1057294990.SGD","SG9999001440.SGD","IE00B2B36J28.USD","BK4139","LU0109394709.USD","IE0002141913.USD","AMGN","LU0889565916.HKD","IE0009355771.USD","LU0868494617.USD","LU1061106388.HKD","IBBQ","BK4566","PBE","BK4599","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663071381","title":"Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2663071381","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663071381?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:51","pubTimestamp":1788169915,"startTime":"0","endTime":"0","summary":"Amgen  said Monday that its cholesterol-lowering drug Repatha reduced the risk of death by 20% in high-risk adults without a prior heart attack or stroke.The findings came from a pre-specified analysis of the phase 3 VESALIUS-CV trial involving more than 12,000 patients and were presented at the European Society of Cardiology Congress 2026 in Munich, it said.Amgen said Repatha reduced both overall and cardiovascular deaths when added to statins or other LDL-C-lowering treatments. The mortality benefit emerged after about 1.5 years and continued through a median follow-up of 4.6 years, it added.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0320765992.SGD","BK4533","LU0889565916.HKD","IBB","BK4585","IE0002141913.USD","PBE","BK4581","AMGN","LU0109394709.USD","BK4139","LU1983299246.USD","BK4566","IE00BJT1NW94.SGD","SG9999001440.SGD","LU2242646821.SGD","PJP","IE00B4R5TH58.HKD","LU2089984988.USD","LU1023059063.AUD","IBBQ","BIB","LU0868494617.USD","TBXU","IE00BFTCPJ56.SGD","BBH","LU1061106388.HKD","IE0009355771.USD","LU2112291526.USD","LU1057294990.SGD","LU1571399168.USD","LU0122379950.USD","IE00B2B36J28.USD","LU2468319806.SGD","LU0289739699.SGD","BK4534","BK4599","IE00BJJMRZ35.SGD","LU0058720904.USD","LU2242652126.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663249076","title":"Amgen Repatha reduces risk of death in high-risk adults for first heart attack","url":"https://stock-news.laohu8.com/highlight/detail?id=2663249076","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663249076?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:10","pubTimestamp":1788167413,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) announced new findings showing Repatha reduced the risk of death in high-risk adults without a prior heart attack or stroke when added...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amgen-repatha-reduces-risk-of-death-in-high-risk-adults-for-first-heart-attack-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amgen-repatha-reduces-risk-of-death-in-high-risk-adults-for-first-heart-attack-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","LU2112291526.USD","LU0122379950.USD","BIB","BK4599","PBE","IBBQ","IE00BJT1NW94.SGD","IBB","IE00B4R5TH58.HKD","LU2089984988.USD","LU0058720904.USD","LU1057294990.SGD","BK4566","LU1023059063.AUD","LU1571399168.USD","SG9999001440.SGD","LU2242652126.USD","BK4588","IE00BJJMRZ35.SGD","PJP","LU2242646821.SGD","AMGN","LU0889565916.HKD","IE00B2B36J28.USD","LU0109394709.USD","LU1061106388.HKD","BK4581","BK4534","BBH","BK4585","LU0868494617.USD","BK4139","TBXU","LU1983299246.USD","IE00BFTCPJ56.SGD","BK4533","LU0320765992.SGD","LU2468319806.SGD","LU0289739699.SGD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663202044","title":"Amgen's Repatha® Reduces Risk of Death in Patients at High Risk for a First Heart Attack or Stroke","url":"https://stock-news.laohu8.com/highlight/detail?id=2663202044","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663202044?lang=en_us&edition=fundamental","pubTime":"2026-08-31 15:18","pubTimestamp":1788160736,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUA6XK0BH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4599","IE0002141913.USD","BK4533","TBXU","IBB","LU0122379950.USD","IE0009355771.USD","LU2242652126.USD","AMGN","IE00BFTCPJ56.SGD","PBE","LU2468319806.SGD","BIB","PJP","LU2089984988.USD","LU0868494617.USD","IE00BJJMRZ35.SGD","LU2242646821.SGD","LU0320765992.SGD","LU1061106388.HKD","SG9999001440.SGD","BK4585","IE00BJT1NW94.SGD","LU1983299246.USD","LU1057294990.SGD","LU2112291526.USD","IE00B4R5TH58.HKD","IBBQ","LU0058720904.USD","IE00B2B36J28.USD","BK4581","BK4588","BK4139","LU0889565916.HKD","BK4566","BBH","LU1023059063.AUD","LU0109394709.USD","LU0289739699.SGD","LU1571399168.USD","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663588047","title":"Protagonist announces Takeda received U.S. FDA approval for MIMRYLO","url":"https://stock-news.laohu8.com/highlight/detail?id=2663588047","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663588047?lang=en_us&edition=fundamental","pubTime":"2026-08-31 04:35","pubTimestamp":1788122107,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics (PTGX) announced that Takeda (TAK) received U.S. Food and Drug Administration, FDA, approval for MIMRYLO, a subcutaneously...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/protagonist-announces-takeda-received-u-s-fda-approval-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/protagonist-announces-takeda-received-u-s-fda-approval-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TECB","FRTY","LABU","NVIB","TAK","PTGX","IBB","PINK","MRNY","GDOC","BK4007","PSCH","SYNB","IDNA","MEDI","BK4588","TBXU","RSPH","IEIH","BMED","BK4139","XLVX","MRNX","LFSC","GNMX","IYH","BK4585","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663043488","title":"Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2663043488","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663043488?lang=en_us&edition=fundamental","pubTime":"2026-08-30 07:30","pubTimestamp":1788046226,"startTime":"0","endTime":"0","summary":"Gilead Sciences stock has delivered very strong gains over the past few years, yet current valuation checks still suggest the shares screen as inexpensive on several metrics. The question for investors is how that strong track record and the latest product approvals align with a profile that continues to lean cheap.\n\nOver 5 years the stock has returned about 143%, which puts recent moves in the context of a long, powerful run that investors now need to judge against today’s pricing.\nThe...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-stays-cheap-after-a-143-five-year-run","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-stays-cheap-after-a-143-five-year-run","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2089984988.USD","LU1934455194.USD","LU1934455277.USD","MEDI","LU2468319806.SGD","BK4568","TBXU","BK4139","LU0289739699.SGD","BK4550","BK4578","LU0965508806.USD","IE00BKVL7J92.USD","IE00B3T34201.USD","BIB","LU0109394709.USD","LU1934455863.HKD","SG9999015978.USD","BK4585","IE00B19Z3B42.SGD","BK4532","LU1066051498.USD","BK4588","LU1839511570.USD","IBBQ","LU0823416689.USD","LU0234570918.USD","GILD","TMED","BBH","LU1066053197.SGD","BK4566","LU0058720904.USD","LU0965509283.SGD","SG9999015945.SGD","LU0965509010.AUD","LU2112291526.USD","IBB","LU1061106388.HKD","LU1430594728.SGD","IE00BZ1G4Q59.USD","LU0114720955.EUR","BMED","LU1585245621.USD","LU1023059063.AUD","LU1571399168.USD","LU0122379950.USD","LU0882574055.USD","LU2324357040.USD","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663019703","title":"Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO","url":"https://stock-news.laohu8.com/highlight/detail?id=2663019703","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663019703?lang=en_us&edition=fundamental","pubTime":"2026-08-29 08:52","pubTimestamp":1787964735,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Co ( ($JP:4502) ) just unveiled an announcement. Takeda has secured U.S. FDA approval for MIMRYLO (rusfertide), a first-in-cl...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-wins-fda-nod-for-first-in-class-polycythemia-vera-therapy-mimrylo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-wins-fda-nod-for-first-in-class-polycythemia-vera-therapy-mimrylo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLVX","PINK","IYH","BMED","MEDI","BK4588","IDNA","FRTY","RSPH","BBP","IBB","MRNY","LABU","IEIH","MRNX","TBXU","GNMX","NVIB","BK4585","SYNB","GDOC","LFSC","TECB","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016033","title":"Takeda receives FDA approval of NDA for Mimrylo","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016033","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663016033?lang=en_us&edition=fundamental","pubTime":"2026-08-29 07:00","pubTimestamp":1787958013,"startTime":"0","endTime":"0","summary":"Takeda (TAK) announced U.S. FDA approval of the New Drug Application for Mimrylo for the treatment of erythrocytosis in adults with polycythemia ve...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-receives-fda-approval-of-nda-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-receives-fda-approval-of-nda-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","RSPH","LFSC","IBB","PINK","MEDI","BBP","SYNB","TAK","GDOC","BK4588","MRNX","LABU","IYH","TBXU","XLVX","FRTY","IEIH","MRNY","TECB","GNMX","BK4007","BMED","IDNA","PSCH","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663015099","title":"Crinetics Shareholders Approve Vertex Acquisition at Special Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2663015099","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663015099?lang=en_us&edition=fundamental","pubTime":"2026-08-29 05:33","pubTimestamp":1787952818,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals ( ($CRNX) ) has provided an update. On August 28, 2026, Crinetics Pharmaceuticals shareholders held a special meeting at ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/crinetics-shareholders-approve-vertex-acquisition-at-special-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/crinetics-shareholders-approve-vertex-acquisition-at-special-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4567","VERX","LU2236285917.USD","LU2468319806.SGD","TBXU","BK4588","IE00BJT1NW94.SGD","LU1093756168.USD","VRTX","IDNA","LU0234570918.USD","LU1815336091.USD","IE00B19Z9P08.USD","PBE","BK4533","BK4532","LU0757428866.USD","LU2362540622.SGD","LU2417539215.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU0823416689.USD","LU2462157665.USD","BIB","SG9999001176.SGD","LU2324357040.USD","LU1674673428.USD","IE00B19Z3B42.SGD","LU1674673691.USD","LU1430594728.SGD","LU1778281490.HKD","LU0432979614.USD","IE0009355771.USD","IE00B19Z3581.USD","IBB","IE0002141913.USD","IE00B894F039.SGD","IE00BZ9MQY76.HKD","LU1069344957.HKD","LU0256863811.USD","IBBQ","BBH","GNMX","LU0079474960.USD","BK4023","LU0061475181.USD","LU0289739699.SGD","LU0320765992.SGD","LU0566484027.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663701587","title":"Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663701587","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663701587?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:35","pubTimestamp":1787949300,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slid 2.14% to $145.68 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,711.76 and Dow Jones Industrial Average  falling 0.02% to 53,559.99.Gilead Sciences Inc. closed 7.38% short of its 52-week high of $157.29, which the company achieved on February 11th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  rose 0.85% to $268.04, Pfizer Inc.  fell 0.21% to $27.96, and Abbott Laboratories  rose 0.79% to $112.47.Trading volume  remained 3.2 million below its 50-day average volume of 7.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","BK4585","LU0234570918.USD","LU0965509283.SGD","LU0965509101.SGD","IBBQ","LU1057294990.SGD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU1571399168.USD","LU1674673691.USD","BK4583","TMED","BK4550","IE00B3T34201.USD","GILD","IE00BZ1G4Q59.USD","LU0965509010.AUD","LU1066051498.USD","LU1839511570.USD","IE0002270589.USD","LU1934455277.USD","LU2357627491.SGD","LU1934455863.HKD","LU2112291526.USD","LU1674673428.USD","TBXU","LU0289739699.SGD","LU0882574055.USD","LU2089984988.USD","LU2468319806.SGD","BK4578","LU1037948897.HKD","LU1066053197.SGD","LU1778281490.HKD","LU1934455194.USD","SG9999015978.USD","BK4139","LU1585245621.USD","IE00B7SZLL34.SGD","LU0114720955.EUR","SG9999015945.SGD","IBB","LU0122379950.USD","BK4532","LU1037948541.HKD","LU0861579265.USD","LU1061106388.HKD","LU0823416689.USD","LU2087621335.USD","IE00BKVL7J92.USD","LU0889565916.HKD","BIB","LU2324357040.USD","IE00BSNM7G36.USD","SG9999015952.SGD","LU0320765992.SGD","LU0965508806.USD","SG9999015986.USD","BK4588","LU0058720904.USD","MEDI","LU1023059063.AUD","LU0109394709.USD","BMED","BK4568","LU0859254822.USD","LU1430594728.SGD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663015807","title":"Amgen Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663015807","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663015807?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:34","pubTimestamp":1787949240,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  slipped 1.05% to $432.42 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,711.76 and Dow Jones Industrial Average  falling 0.02% to 53,559.99.This was the stock's fourth consecutive day of losses.Amgen Inc. closed 3.27% below its 52-week high of $447.03, which the company reached on August 25th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  rose 0.85% to $268.04, Pfizer Inc.  fell 0.21% to $27.96, and AbbVie Inc.  fell 1.03% to $255.48.Trading volume  remained 889,592 below its 50-day average volume of 2.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU1983299246.USD","BK4533","LU2468319806.SGD","AMGN","IE00BFTCPJ56.SGD","IE0002141913.USD","LU0889565916.HKD","IE0009355771.USD","TBXU","LU2242646821.SGD","04332","LU1023059063.AUD","BK4581","BBH","LU2242652126.USD","BK4585","IBB","LU0109394709.USD","BK4599","LU1057294990.SGD","PBE","PJP","LU1061106388.HKD","BIB","LU2112291526.USD","LU0122379950.USD","LU0868494617.USD","IBBQ","BK4139","LU0320765992.SGD","BK4588","SG9999001440.SGD","BK4534","LU1571399168.USD","LU0058720904.USD","IE00B2B36J28.USD","LU2089984988.USD","IE00BJT1NW94.SGD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663018885","title":"Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo","url":"https://stock-news.laohu8.com/highlight/detail?id=2663018885","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663018885?lang=en_us&edition=fundamental","pubTime":"2026-08-29 01:20","pubTimestamp":1787937637,"startTime":"0","endTime":"0","summary":"Gilead Sciences stock was down roughly 2% on Friday alongside an FDA update concerning HIV drug Bixlenvo.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/gilead-sciences-stock-gild-slips-2-despite-fda-approval-of-bixlenvo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/gilead-sciences-stock-gild-slips-2-despite-fda-approval-of-bixlenvo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4578","SG9999015978.USD","LU2112291526.USD","IBBQ","TMED","LU0859254822.USD","IE00B19Z3581.USD","LU0320765992.SGD","LABU","LU1674673691.USD","LU0114720955.EUR","LU1934455277.USD","LU2357627491.SGD","BK4566","GILD","MEDI","IE00B7SZLL34.SGD","IE00BKVL7J92.USD","LU0965509010.AUD","LU1585245621.USD","LU1778281490.HKD","LU0122379950.USD","IE00B19Z3B42.SGD","LU0965509101.SGD","SG9999015986.USD","BK4532","LU0823416689.USD","LU1066051498.USD","IBB","LU1934455863.HKD","LU0109394709.USD","BK4139","LU0889565916.HKD","LU1057294990.SGD","LU1066053197.SGD","BMED","LU1934455194.USD","IE00B3T34201.USD","SG9999015945.SGD","BK4585","IE0002270589.USD","LU1571399168.USD","BBH","BIB","TBXU","LU0882574055.USD","LU1037948897.HKD","BK4588","IE00BSNM7G36.USD","LU1037948541.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663097210","title":"Vertex Tests VX-407’s Impact on Birth Control: What It Means for VRTX Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663097210","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663097210?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:30","pubTimestamp":1787934634,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals Inc. ($VRTX) announced an update on their ongoing clinical study. Vertex’s new Phase 1 study, officially titled “A Phase 1, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-tests-vx-407s-impact-on-birth-control-what-it-means-for-vrtx-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-tests-vx-407s-impact-on-birth-control-what-it-means-for-vrtx-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4211","SGXZ57979304.SGD","SG9999001176.USD","IE00BJT1NW94.SGD","LU1815336091.USD","LU2362541513.USD","LU0823416689.USD","LU1674673428.USD","LU1093756325.SGD","TBXU","LU1559883803.SGD","BK4023","IE00B2B36J28.USD","VRTX","LU2324357040.USD","GNMX","LU0417517546.SGD","LU2362540622.SGD","IE00B19Z3581.USD","LU2237438978.USD","IBB","SG9999001176.SGD","BK4567","IE0009355771.USD","IE00B19Z9Z06.USD","BIB","LU0566484027.USD","IE00B894F039.SGD","ISBC","LU0058720904.USD","IDNA","VERX","BK4532","IBBQ","SG9999013999.USD","IE00BZ9MQY76.HKD","LU2362541273.HKD","BK4588","LU2468319806.SGD","LU1585245621.USD","LU0889565916.HKD","LU0320765992.SGD","BBH","BK4139","LU1430594728.SGD","LU2089984988.USD","BK4585","IE0002270589.USD","LU2417539215.USD","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663225097","title":"Amgen’s Pediatric Psoriasis Study Wrap-Up: What Apremilast Safety Data Means for Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663225097","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663225097?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:30","pubTimestamp":1787934627,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen’s latest psoriasis study update spotlights apremilast (AMG 407) for ki...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgens-pediatric-psoriasis-study-wrap-up-what-apremilast-safety-data-means-for-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgens-pediatric-psoriasis-study-wrap-up-what-apremilast-safety-data-means-for-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBH","BK4585","BK4599","LU1057294990.SGD","IBBQ","LU1571399168.USD","AMGN","IE00B2B36J28.USD","PJP","BK4534","IE00BJJMRZ35.SGD","ISBC","PBE","LU2112291526.USD","BK4581","LU0289739699.SGD","TBXU","LU2089984988.USD","LU2468319806.SGD","BK4139","LU2242652126.USD","IBB","LU0122379950.USD","IE0009355771.USD","LU0868494617.USD","LU1061106388.HKD","SG9999001440.SGD","LU0889565916.HKD","BIB","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0320765992.SGD","LU2242646821.SGD","BK4588","LU0058720904.USD","LU1983299246.USD","BK4211","BK4533","LU1023059063.AUD","IE0002141913.USD","IE00BJT1NW94.SGD","LU0109394709.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662098405","title":"Political and General News Events from August 28","url":"https://stock-news.laohu8.com/highlight/detail?id=2662098405","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662098405?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:30","pubTimestamp":1787920229,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from August 28Aug 28 (Reuters)-For other diaries, please see:Political andGeneral NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG/DI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL4N44P0YN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","IE00BFTCPJ56.SGD","BBH","LU0109394709.USD","PJP","BK4599","LU1023059063.AUD","BK4588","LU1061106388.HKD","LU2468319806.SGD","TBXU","LU2112291526.USD","BIB","IBBQ","BK4585","IE00BJT1NW94.SGD","IE0002141913.USD","BK4534","LU0889565916.HKD","IBB","LU1983299246.USD","LU2242652126.USD","LU0289739699.SGD","IE00B2B36J28.USD","LU0058720904.USD","LU1057294990.SGD","LU2242646821.SGD","BK4566","BK4533","LU0320765992.SGD","BK4139","LU0868494617.USD","LU1571399168.USD","SG9999001440.SGD","PBE","IE00B4R5TH58.HKD","AMGN","LU0122379950.USD","BK4581","LU2089984988.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662762030","title":"Gilead Breaks Ground on Foster City Biologics Facility in $32 Billion US Investment Push","url":"https://stock-news.laohu8.com/highlight/detail?id=2662762030","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662762030?lang=en_us&edition=fundamental","pubTime":"2026-08-28 10:17","pubTimestamp":1787883449,"startTime":"0","endTime":"0","summary":"Gilead breaks ground on Foster City biologics facility in $32 billion US investment pushGilead broke ground on its Chess biologics facility at its Foster City, California headquarters as part of a pla","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL98vB5b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","LU1066053197.SGD","BMED","LU1934455863.HKD","BK4588","LU1037948541.HKD","IE0002270589.USD","LU0109394709.USD","LU0289739699.SGD","LU1430594728.SGD","LU1057294990.SGD","BK4568","LU2324357040.USD","LU0861579265.USD","LU2357627491.SGD","LU0965509010.AUD","LU1066051498.USD","LU1571399168.USD","LU2112291526.USD","BBH","LU1934455194.USD","BK4532","IBB","LU0234570918.USD","BK4578","IE00BSNM7G36.USD","LU0859254822.USD","LU0320765992.SGD","LU0889565916.HKD","TBXU","SG9999015952.SGD","LU1674673691.USD","BK4583","LU0823416689.USD","IE00BKVL7J92.USD","LU2087621335.USD","LU1674673428.USD","IBBQ","LU1061106388.HKD","LU0965508806.USD","MEDI","GILD","LU0965509283.SGD","LU1037948897.HKD","IE00B7SZLL34.SGD","LU0965509101.SGD","LU0058720904.USD","BIB","TMED","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662394370","title":"Gilead Sciences Director Anthony Welters Disposes of USD 2.64 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2662394370","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662394370?lang=en_us&edition=fundamental","pubTime":"2026-08-28 06:45","pubTimestamp":1787870729,"startTime":"0","endTime":"0","summary":"Gilead Sciences director Anthony Welters disposes of USD 2.64 million in common sharesGilead director Anthony Welters exercised stock options for 18,000 shares on Aug. 26, 2026 at prices of USD 60.67 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL29Bbzm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead Sciences Director Anthony Welters Disposes of USD 2.64 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","LU0965509101.SGD","IE00BSNM7G36.USD","LU2112291526.USD","LU1057294990.SGD","BK4139","LU0861579265.USD","LU1674673428.USD","LU0965508806.USD","BMED","LU1037948897.HKD","LU1066051498.USD","LU0289739699.SGD","LU1571399168.USD","LU1585245621.USD","LU0320765992.SGD","TMED","GILD","IBBQ","LU0058720904.USD","LU1839511570.USD","TBXU","BK4568","MEDI","BK4585","BK4532","LU0965509010.AUD","LU1430594728.SGD","LU0859254822.USD","LU2087621335.USD","BK4566","LU1934455863.HKD","BIB","IE00B3T34201.USD","IE00B19Z3581.USD","BK4578","IE00B7SZLL34.SGD","BBH","LU0889565916.HKD","LU2324357040.USD","LU1023059063.AUD","BK4583","IE00B19Z3B42.SGD","LU1061106388.HKD","BK4588","LU0122379950.USD","IE0002270589.USD","SG9999015986.USD","LU0823416689.USD","IBB"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}